股票 › PRAX
普拉西斯精准医疗 PRAX
美股市值排名 #1675
$277.62 +$15.03 (+5.72%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $279.00 +0.50%
开盘$267.28
昨收$262.59
当日区间$260.77 – $278.98
成交量320.9K
市值$7.75B
市盈率（TTM）–
股息率–
PRAX 相关新闻
匹配 Praxis Precision Medicines 或代码 PRAX 的头条新闻，按最新排序。
- Needham Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $582
- A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $441 to $1,201
- LifeSci Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $754
- A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $462 to $800
- H.C. Wainwright Sticks to Its Buy Rating for Praxis Precision Medicines (PRAX)
- Goldman Sachs Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $575
- Goldman Sachs Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $575 正面
- Oppenheimer Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $650
- Raymond James Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Announces Target Price $945
- LifeSci Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $719
- Jefferies Initiates Praxis Precision Medicines(PRAX.US) With Buy Rating, Announces Target Price $447
- Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $1,200
- RBC Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $449
- Guggenheim Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $800
- Jefferies Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $550
暂无评论——快来第一个聊聊 PRAX。
登录后参与讨论。